RxDoctor Payments DataLook up a doctor →

Wallace Hoke, MD

Family Medicine · Jonesboro, ARNPI 1386605475

Payments from drug & device makers

$16,352in general payments, 2019–2025

Across 1,134 payments — averaging $14.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$2K
  • AbbVie$2K
  • AstraZeneca$2K
  • Novo Nordisk$1K
  • Lilly USA, LLC$1K
  • Amgen$987
  • plus $7K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer167$1,997
AbbVie(2 entities)162$1,954
AstraZeneca68$1,903
Novo Nordisk106$1,433
Lilly USA, LLC91$1,076
Amgen(2 entities)77$987
Takeda Pharmaceuticals U.S.A., Inc.47$669
Otsuka America Pharmaceutical, Inc.26$562
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC34$527
GSK37$508
Merck45$498
Boehringer Ingelheim34$473
Novartis24$415
Bayer23$408
Astellas Pharma US Inc22$362
Lundbeck LLC15$239
Biohaven Pharmaceutical Holding Company Ltd.16$203
Biohaven Pharmaceuticals, Inc.13$183
Idorsia Pharmaceuticals US Inc8$180
Sanofi-aventis U.S. LLC16$157
Johnson & Johnson9$123
Nestle Healthcare Nutrition Inc.7$115
Esperion Therapeutics, Inc.9$115
Antares Pharma, Inc.5$99
E.r. Squibb & Sons, L.L.C.6$97
Exact Sciences6$93
Amarin Pharma, Inc.5$75
Medtronic1$75
Eisai Inc.5$66
Upsher-smith Laboratories LLC5$60
Ironshore Pharmaceuticals Inc.3$58
Currax Pharmaceuticals LLC4$53
Genentech USA, Inc.3$45
Teva Pharmaceuticals USA, Inc.3$44
Shire North American Group Inc3$40
Supernus Pharmaceuticals, Inc.3$38
Aimmune Therapeutics, Inc.2$37
Edwards Lifesciences1$37
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$30
Springworks Therapeutics, Inc.1$29
Phathom Pharmaceuticals, Inc.3$28
Kowa Pharmaceuticals America, Inc.2$25
Impel Pharmaceuticals Inc.1$24
Sunovion Pharmaceuticals Inc.1$21
Vertex1$19
Axsome Therapeutics, Inc.1$16
Abbott1$16
Dexcom, Inc.1$15
Acella Pharmaceuticals, LLC1$15
Bausch Health US, LLC1$15
Shield Therapeutics Inc1$14
Nalpropion Pharmaceuticals LLC1$13
Xeris Pharmaceuticals, Inc.1$13
Advanced Respiratory, Inc1$13
Ironwood Pharmaceuticals, Inc1$13
Philips North America LLC1$12
Mylan Specialty L.p.1$12

How this compares

$16,352 in reported general payments places this provider in the 95th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas →

Medicare billing

Part B allowed, 2024
$144,265
Medicare patients
326
Services billed
7,955

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Jonesboro

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →